346 related articles for article (PubMed ID: 16210610)
1. Receptor editing can lead to allelic inclusion and development of B cells that retain antibodies reacting with high avidity autoantigens.
Liu S; Velez MG; Humann J; Rowland S; Conrad FJ; Halverson R; Torres RM; Pelanda R
J Immunol; 2005 Oct; 175(8):5067-76. PubMed ID: 16210610
[TBL] [Abstract][Full Text] [Related]
2. Development of myelin oligodendrocyte glycoprotein autoreactive transgenic B lymphocytes: receptor editing in vivo after encounter of a self-antigen distinct from myelin oligodendrocyte glycoprotein.
Litzenburger T; Blüthmann H; Morales P; Pham-Dinh D; Dautigny A; Wekerle H; Iglesias A
J Immunol; 2000 Nov; 165(9):5360-6. PubMed ID: 11046072
[TBL] [Abstract][Full Text] [Related]
3. Tolerance through indifference: autoreactive B cells to the nuclear antigen La show no evidence of tolerance in a transgenic model.
Aplin BD; Keech CL; de Kauwe AL; Gordon TP; Cavill D; McCluskey J
J Immunol; 2003 Dec; 171(11):5890-900. PubMed ID: 14634099
[TBL] [Abstract][Full Text] [Related]
4. Foxo3 Promotes Apoptosis of B Cell Receptor-Stimulated Immature B Cells, Thus Limiting the Window for Receptor Editing.
Ottens K; Hinman RM; Barrios E; Skaug B; Davis LS; Li QZ; Castrillon DH; Satterthwaite AB
J Immunol; 2018 Aug; 201(3):940-949. PubMed ID: 29950509
[TBL] [Abstract][Full Text] [Related]
5. B cell tolerance checkpoints that restrict pathways of antigen-driven differentiation.
William J; Euler C; Primarolo N; Shlomchik MJ
J Immunol; 2006 Feb; 176(4):2142-51. PubMed ID: 16455970
[TBL] [Abstract][Full Text] [Related]
6. Antinuclear antigen B cells that down-regulate surface B cell receptor during development to mature, follicular phenotype do not display features of anergy in vitro.
Liu X; Manser T
J Immunol; 2005 Apr; 174(8):4505-15. PubMed ID: 15814671
[TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of the relative contributions of deletion, anergy, and editing to B cell self-tolerance.
Hippen KL; Schram BR; Tze LE; Pape KA; Jenkins MK; Behrens TW
J Immunol; 2005 Jul; 175(2):909-16. PubMed ID: 16002689
[TBL] [Abstract][Full Text] [Related]
8. Ig light chain receptor editing in anergic B cells.
Tze LE; Baness EA; Hippen KL; Behrens TW
J Immunol; 2000 Dec; 165(12):6796-802. PubMed ID: 11120801
[TBL] [Abstract][Full Text] [Related]
9. Progressive surface B cell antigen receptor down-regulation accompanies efficient development of antinuclear antigen B cells to mature, follicular phenotype.
Heltemes-Harris L; Liu X; Manser T
J Immunol; 2004 Jan; 172(2):823-33. PubMed ID: 14707052
[TBL] [Abstract][Full Text] [Related]
10. IL-4 promotes Stat6-dependent survival of autoreactive B cells in vivo without inducing autoantibody production.
Morris SC; Dragula NL; Finkelman FD
J Immunol; 2002 Aug; 169(4):1696-704. PubMed ID: 12165489
[TBL] [Abstract][Full Text] [Related]
11. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
[TBL] [Abstract][Full Text] [Related]
12. Receptor editing and genetic variability in human autoreactive B cells.
Lang J; Ota T; Kelly M; Strauch P; Freed BM; Torres RM; Nemazee D; Pelanda R
J Exp Med; 2016 Jan; 213(1):93-108. PubMed ID: 26694971
[TBL] [Abstract][Full Text] [Related]
13. Ig allotypic inclusion does not prevent B cell development or response.
Velez MG; Kane M; Liu S; Gauld SB; Cambier JC; Torres RM; Pelanda R
J Immunol; 2007 Jul; 179(2):1049-57. PubMed ID: 17617597
[TBL] [Abstract][Full Text] [Related]
14. Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.
Bonami RH; Thomas JW
J Immunol; 2015 Nov; 195(10):4730-41. PubMed ID: 26432895
[TBL] [Abstract][Full Text] [Related]
15. Allelic and isotypic light chain inclusion in peripheral B cells from anti-DNA antibody transgenic C57BL/6 and BALB/c mice.
Witsch EJ; Bettelheim E
J Immunol; 2008 Mar; 180(6):3708-18. PubMed ID: 18322176
[TBL] [Abstract][Full Text] [Related]
16. Late immature B cells (IgMhighIgDneg) undergo a light chain receptor editing response to soluble self-antigen.
Tze LE; Hippen KL; Behrens TW
J Immunol; 2003 Jul; 171(2):678-82. PubMed ID: 12847233
[TBL] [Abstract][Full Text] [Related]
17. Specific antigen-binding and antibody-secreting lymphocytes associated with the erythrocyte autoantibody responses of NZB and genetically unrelated mice.
DeHeer DH; Edgington TS
J Immunol; 1976 Apr; 116(4):1051-8. PubMed ID: 1082901
[TBL] [Abstract][Full Text] [Related]
18. Activation of the MEK-ERK Pathway Is Necessary but Not Sufficient for Breaking Central B Cell Tolerance.
Greaves SA; Peterson JN; Torres RM; Pelanda R
Front Immunol; 2018; 9():707. PubMed ID: 29686680
[TBL] [Abstract][Full Text] [Related]
19. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement.
Lau CM; Broughton C; Tabor AS; Akira S; Flavell RA; Mamula MJ; Christensen SR; Shlomchik MJ; Viglianti GA; Rifkin IR; Marshak-Rothstein A
J Exp Med; 2005 Nov; 202(9):1171-7. PubMed ID: 16260486
[TBL] [Abstract][Full Text] [Related]
20. Active PI3K abrogates central tolerance in high-avidity autoreactive B cells.
Greaves SA; Peterson JN; Strauch P; Torres RM; Pelanda R
J Exp Med; 2019 May; 216(5):1135-1153. PubMed ID: 30948496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
